Company / Working Capital
PROKIDNEY CORP. Working Capital History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$359.7M
FY2024
5-year range
$15.0M / $493.8M
FY2021-FY2024
Trend
+3.0%
vs FY2023
Sector context
#120 of 213
Health Care
What the data says
At $360M, PROKIDNEY CORP.'s working capital ranks #120 of 213 in the Health Care sector. Declined from $494M to $360M over the past 2 years.
Based on SEC 10-K filings.
$360M in FY2024 with a 3-year CAGR of +188.6%.
Declined from $494M to $360M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +188.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#120 of 213 in Health CareTop 56% of 213This company $359.7M Sector average $934.6M
▼
-61.5% below sector average
Key checks
Key Insights
- 3-year CAGR of +188.6%, indicating consistent growth.
- In FY2024, working capital increased 3.0% year-over-year.
- Ranks #120 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -1.00 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $359.7M | +3.0% |
| FY2023 | $349.1M | -29.3% |
| FY2022 | $493.8M | +3201.8% |
| FY2021 | $15.0M | - |
| FY2020 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026